Dermisonics Net Income vs. Total Asset

DMSI Stock  USD 0.00003  0.00  0.00%   
Based on Dermisonics' profitability indicators, Dermisonics may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Dermisonics' ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-4.6 M
Current Value
-4.8 M
Quarterly Volatility
1.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
As of now, Dermisonics' Current Ratio is decreasing as compared to previous years. The Dermisonics' current Shareholders Equity Per Share is estimated to increase to 0.37, while PTB Ratio is projected to decrease to 1.04.
For Dermisonics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dermisonics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dermisonics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dermisonics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dermisonics over time as well as its relative position and ranking within its peers.
Check out Investing Opportunities.
For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.
Is Medical Devices space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermisonics. If investors know Dermisonics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermisonics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.44)
Return On Assets
(0.12)
Return On Equity
(3.92)
The market value of Dermisonics is measured differently than its book value, which is the value of Dermisonics that is recorded on the company's balance sheet. Investors also form their own opinion of Dermisonics' value that differs from its market value or its book value, called intrinsic value, which is Dermisonics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermisonics' market value can be influenced by many factors that don't directly affect Dermisonics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermisonics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermisonics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermisonics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Dermisonics Total Asset vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Dermisonics's current stock value. Our valuation model uses many indicators to compare Dermisonics value to that of its competitors to determine the firm's financial worth.
Dermisonics is one of the top stocks in net income category among its peers. It also is one of the top stocks in total asset category among its peers . The last year's value of Net Loss was reported at (4.58 Million). The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dermisonics' earnings, one of the primary drivers of an investment's value.

Dermisonics Total Asset vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Dermisonics

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(5.08 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Dermisonics

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
20.08 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Dermisonics Total Asset Comparison

Dermisonics is currently under evaluation in total asset category among its peers.

Dermisonics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Dermisonics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Dermisonics will eventually generate negative long term returns. The profitability progress is the general direction of Dermisonics' change in net profit over the period of time. It can combine multiple indicators of Dermisonics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-3.7 M-3.9 M
Net Loss-4.6 M-4.8 M
Income Before Tax-4.6 M-4.8 M
Total Other Income Expense Net-874.8 K-918.6 K
Net Loss-4.6 M-4.8 M
Net Loss-4.6 M-4.8 M
Change To Netincome3.5 MM
Net Loss(0.13)(0.14)
Income Quality 0.30  0.37 

Dermisonics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Dermisonics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Dermisonics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Dermisonics' important profitability drivers and their relationship over time.

Use Dermisonics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dermisonics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermisonics will appreciate offsetting losses from the drop in the long position's value.

Dermisonics Pair Trading

Dermisonics Pair Trading Analysis

The ability to find closely correlated positions to Dermisonics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dermisonics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dermisonics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dermisonics to buy it.
The correlation of Dermisonics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dermisonics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dermisonics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dermisonics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Dermisonics position

In addition to having Dermisonics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alcohol Thematic Idea Now

Alcohol
Alcohol Theme
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 9 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Dermisonics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dermisonics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dermisonics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dermisonics Stock:
Check out Investing Opportunities.
For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
To fully project Dermisonics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Dermisonics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Dermisonics' income statement, its balance sheet, and the statement of cash flows.
Potential Dermisonics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Dermisonics investors may work on each financial statement separately, they are all related. The changes in Dermisonics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dermisonics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.